Table 6.
Top 10 most cited articles
| Rank | Co-cited reference | Co-citation |
|---|---|---|
| 1 | Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. | 126 |
| 2 | Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease. | 96 |
| 3 | Infliximab for the treatment of fistulas in patients with Crohn’s disease. | 65 |
| 4 | Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn’s Disease. | 63 |
| 5 | A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. | 54 |
| 6 | Infliximab maintenance therapy for fistulizing Crohn’s disease. | 52 |
| 7 | Modern management of perianal fistulas in Crohn’s disease: future directions. | 51 |
| 8 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations. | 50 |
| 9 | Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial. | 50 |
| 10 | Perianal fistulizing Crohn’s disease: pathogenesis, diagnosis and therapy. | 43 |